Delivery Order SPE2DB24D3013-SPE2DB25FFFXN

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024 with a ceiling value of $6,356.61. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 1, 2024. This award...
This federal contract award is for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,323.57, and has an ultimate completion date of July 15,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The $1,093.30 firm fixed-price delivery order has a completion date of September 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of Victoza 3-pak 18 mg/3 ml pens to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $2,301.87 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 26, 2024 and was awarded on September 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,404.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award for $1,323.57 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a delivery order type and firm fixed price pricing, is for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The award has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the supply of Victoza 3-pak 18 mg/3 ml pen 3 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,523.97 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 14, 2024. The contract has an ultimate completion date of August 15, 2024 and is not a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Victoza 3-Pak 18 mg/3 mL pens to the Defense Logistics Agency (DLA). The $6,575.04 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company...
This federal contract award, valued at $1,343.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a specialty medication, with an ultimate completion date of June 11, 2024. The contract is a firm fixed-price arrangement, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant...
This federal contract award, valued at $3,359.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a specialty pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a comprehensive...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFFXN
    Delivery Order

This federal contract award is for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML pharmaceuticals to the Defense Logistics Agency (DLA). The $1,772.91 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024, with a completion date of October 25, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 1/23/25, 9:16 AM